ArticleInternational journal of biomaterials2026
Nanocomposite Bone Scaffolds Based on Magnesium Alloy: A Detailed Investigation of Their In-Vitro Biodegradation Performance.
Article in International journal of biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanocomposite Bone Scaffolds Based on Magnesium Alloy: A Detailed Investigation of Their In-Vitro Biodegradation Performance.International journal of biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polymeric biomaterials and their composites have been extensively explored for orthopaedic applications; however, their inadequate mechanical performance significantly restricts their use in load-bearing environments. Metallic biomaterials, by contrast, offer superior mechanical strength and structural stability. Among them, magnesium (Mg) has emerged as a particularly attractive candidate for temporary orthopaedic implants owing to its elastic modulus and density being close to those of natural bone, thereby minimising stress shielding. In addition, Mg inherently fulfils two critical requirements for orthopaedic implants-biocompatibility and biodegradability. In this study, a bioactive magnesium-alloy-based nanocomposite scaffold was engineered to overcome the limitations of conventional biomaterials while closely replicating the porous microarchitecture of human bone. A novel bioactive glass-ceramic, nano-fluorcanasite (n-FC), was incorporated into the Mg-alloy matrix to enhance osteogenic activity and accelerate bone tissue regeneration. The introduction of an interconnected porous structure was designed to promote efficient nutrient diffusion, facilitate metabolic waste removal and reduce implant density. Furthermore, the controlled addition of selected alloying elements in specific weight fractions effectively moderated the degradation kinetics of the Mg-based scaffold. The nanocomposite scaffolds were fabricated using a powder metallurgy route followed by sintering. Tailored porosity was achieved through the controlled incorporation of carbamide particles as a space-holding agent. The in vitro degradation behaviour of the scaffolds was systematically evaluated using a weight-change method after immersion in phosphate-buffered saline (PBS) for predetermined durations. The results demonstrate that, compared with unalloyed magnesium, the degradation rate of the nanocomposite scaffolds can be precisely and consistently regulated, highlighting their potential as mechanically competent, bioactive and biodegradable candidates for orthopaedic implant applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.